Unlocking disease treatment with large-scale research
pharmaphorum
DECEMBER 6, 2022
Genetic testing companies, such as 23andMe , provide a service to check consumers’ genetic background, whilst also using the data gathered to collaborate with pharma companies on potential treatments. This makes it difficult to diagnose MS early. Breakthroughs to come.
95 
Let's personalize your content